Innospark Ventures Team
Photo of Matt Fates, Partner at Innospark Ventures
Matt Fates
Sweet spot: $1.5M
Range: $500K - $4.0M
Investors in Boston / New England, Investors in New York (NY), Investors in Toronto (Ontario), Investors in Washington (DC), Investors in Philadelphia (PA)
Investors in BioTech (Seed), Investors in BioTech (Pre-seed), Investors in BioTech (Seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health IT (Seed), Investors in Health IT (Pre-seed), Investors in DeepTech (Pre-seed), Investors in DeepTech (Seed), Investors in DeepTech (Seed), Investors in Analytics (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Seed), Investors in DeepTech (Pre-seed), Investors in Analytics (Seed), Investors in DeepTech (Pre-seed), Investors in AI (Pre-seed), Investors in Analytics (Seed), Investors in AI (Seed), Investors in AI (Pre-seed), Investors in DeepTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in DeepTech (Seed), Investors in SaaS (Seed), Investors in Analytics (Pre-seed), Investors in DeepTech (Seed), Investors in AI (Seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in SaaS (Seed), Investors in Analytics (Seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Pre-seed), Investors in Health IT (Seed), Investors in Analytics (Pre-seed), Investors in DeepTech (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in AI (Seed), Investors in Analytics (Seed), Investors in SaaS (Seed), Investors in DeepTech (Seed), Investors in Health IT (Seed), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in BioTech (Pre-seed), Investors in Analytics (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Analytics (Seed), Investors in BioTech (Seed), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in British Columbia (Other Lists), Investors in Health IT (Seed), Investors in Washington, D.C. (Other Lists), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in New York City (Other Lists)
to see your intro paths to Matt
JK
Jeff Knox
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Drug Delivery (Pre-seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Therapeutics (Pre-seed), Investors in Generative Tech/AI (Series A), Investors in Generative Tech/AI (Pre-seed), Investors in Therapeutics (Series A), Investors in Generative Tech/AI (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Seed), Investors in Medical Devices (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Pre-seed), Investors in Boston / New England (Other Lists), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Health IT (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Health IT (Seed)
to see your intro paths to Jeff
Photo of Mark Legare, Senior Associate at Innospark Ventures
Mark Legare
Innospark Ventures·Senior Associate
Sweet spot: $1.5M
Range: $50K - $4.0M
Investors in Diagnostics (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Robotics (Pre-seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in DeepTech (Series A), Investors in Robotics (Series A), Investors in DeepTech (Seed), Investors in Digital Health (Pre-seed), Investors in Robotics (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Health IT (Pre-seed), Investors in SaaS (Pre-seed), Investors in Medical Devices (Seed), Investors in AI (Pre-seed), Investors in Medical Devices (Series A), Investors in FinTech (Pre-seed), Investors in AI (Series A), Investors in SaaS (Series A), Investors in AI (Seed), Investors in SaaS (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Robotics (Pre-seed), Investors in FinTech (Series A), Investors in DeepTech (Pre-seed), Investors in FinTech (Seed), Investors in Robotics (Series A), Investors in Digital Health (Pre-seed), Investors in Medical Devices (Series A), Investors in DeepTech (Series A), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in DeepTech (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in Boston / New England (Other Lists), Investors in AI (Pre-seed), Investors in SaaS (Pre-seed), Investors in FinTech (Pre-seed), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in SaaS (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Mark
Photo of Venkat Srinivasan, Managing Director at Innospark Ventures
Venkat Srinivasan
Innospark Ventures·Managing Director
Sweet spot: $0
Range: $0 - $0
Investors in Boston (MA), Investors in Boston / New England
Investors in Education (Pre-seed), Investors in Security (Series B), Investors in Education (Series B), Investors in Security (Pre-seed), Investors in Education (Series A), Investors in Security (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Series B), Investors in SaaS (Series B), Investors in AI (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Enterprise (Series B), Investors in SaaS (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Education (Series B), Investors in Security (Series B), Investors in Security (Pre-seed), Investors in Education (Pre-seed), Investors in Security (Series A), Investors in Education (Series A), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Series B), Investors in SaaS (Series B), Investors in AI (Pre-seed), Investors in Health & Hospital Services (Series A), Investors in AI (Series B), Investors in SaaS (Pre-seed), Investors in Enterprise (Pre-seed), Investors in Enterprise (Series B), Investors in AI (Series A), Investors in SaaS (Series A), Investors in Enterprise (Series A), Investors in Boston / New England (Other Lists)
to see your intro paths to Venkat